Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
With lifestyle coaching from Doctor On Demand, your employees have access to the counseling, motivation and reinforcement they need to stay on track
Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety
doi:10.1016/j.amjmed.2009.05.027 Magkos F, Fraterrigo G, Yoshino J, et al
Primary outcome: Percentage change in body weight and the proportion of participants who lost at least 5% of baseline weight by week 68 Results: Primary outcome (% weight loss): Wegovy - 16%, Placebo - 5.7% (p 35 - 68.9% Randomized treatment groups Group 1 (374 patients): Tirzepatide titrated to the maximum tolerated dose of 10 mg or 15 mg once weekly Group 2 (376 patients): Semaglutide titrated to the maximum tolerated dose of 1.7 mg or 2.4 mg once weekly Tirzepatide was initiated at a dose of 2.5 mg once weekly, and the dose was increased by 2.5 mg every 4 weeks until a maximum tolerated dose of 10 mg or 15 mg was reached
:format(webp))
